✦ LIBER ✦

MS3 A DEMONSTRATION OF THE USE OF BAYESIAN DECISION THEORY TO OPTIMISE DRUG DEVELOPMENT PROGRAMMES

✍ Scribed by NS Hawkins; K Claxton

Book ID: 119592546
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 73 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61624-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE DEVELOPMENT OF A SPATIAL DECISION SU

THE DEVELOPMENT OF A SPATIAL DECISION SUPPORT SYSTEM TO OPTIMISE AGRICULTURAL RESOURCE USE IN THE WESTERN CAPE

✍ Pretorius, C.; Louw, D. B.; Kleynhans, T. E. 📂 Article 📅 2000 🏛 Sabinet Online 🌐 English ⚖ 922 KB

Synthesis of d3-cerivastatin for use as

Synthesis of d3-cerivastatin for use as internal standard in a LC/MS/MS method developed for quantitation of the drug in human serum

✍ Bang-Chi Chen; Mark S. Bednarz; Huiping Zhang; Peng Guo; Mohammed Jemal; Jeffrey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 111 KB

## Abstract d~3~‐Cerivastatin was synthesized as an internal standard for use in a LC/MS/MS method developed for the simultaneous quantitative determination of the drug in human serum. d~3~‐Cerivastatin was efficiently prepared on large scale from d~3~‐iodomethane using improved procedures. Copyrig

CV3 THE USE OF A PROBABILISTIC DECISION

CV3 THE USE OF A PROBABILISTIC DECISION MODEL TO ASSESS THE COST-EFFECTIVENESS OF DRUG-ELUTING STENTS IN ALTERNATIVE PATIENT SUB-GROUPS

✍ M Sculpher; NS Hawkins 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

The use of health economics to guide dru

The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach

✍ J.M. Bos; E. Rietveld; H.A. Moll; E.W. Steyerberg; W. Luytjes; J.C. Wilschut; R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Development of a control system using th

Development of a control system using the fuzzy set theory applied to a browning process––towards a control system of the browning process combining a diagnosis model and a decision model––part II

✍ I. Ioannou; N. Perrot; G. Mauris; G. Trystram 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 310 KB

From toxicological problem to therapeuti

From toxicological problem to therapeutic use: The discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug

✍ E. A. Lock; M. K. Ellis; P. Gaskin; M. Robinson; T. R. Auton; W. M. Provan; L. L 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 174 KB